HealthEquity Inc. (HQY) VP Sells $838,750.00 in Stock
HealthEquity Inc. (NASDAQ:HQY) VP Jon Soldan sold 25,000 shares of the firm’s stock in a transaction dated Monday, September 12th. The shares were sold at an average price of $33.55, for a total value of $838,750.00. Following the sale, the vice president now owns 10,000 shares in the company, valued at $335,500. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
HealthEquity Inc. (NASDAQ:HQY) opened at 34.68 on Monday. The firm has a 50-day moving average of $30.62 and a 200-day moving average of $27.24. The stock has a market capitalization of $2.03 billion, a price-to-earnings ratio of 88.92 and a beta of 1.65. HealthEquity Inc. has a 1-year low of $15.80 and a 1-year high of $35.78.
HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.03. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The business earned $44.20 million during the quarter. During the same period in the previous year, the company posted $0.08 earnings per share. HealthEquity’s quarterly revenue was up 44.9% on a year-over-year basis. Equities research analysts anticipate that HealthEquity Inc. will post $0.51 EPS for the current year.
Large investors have recently made changes to their positions in the stock. Macquarie Group Ltd. acquired a new stake in shares of HealthEquity during the second quarter worth approximately $2,309,000. Mason Street Advisors LLC acquired a new stake in shares of HealthEquity during the second quarter worth approximately $210,000. Public Employees Retirement System of Ohio boosted its stake in shares of HealthEquity by 10.4% in the second quarter. Public Employees Retirement System of Ohio now owns 158,629 shares of the company’s stock worth $4,820,000 after buying an additional 15,000 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of HealthEquity by 10.8% in the second quarter. Schwab Charles Investment Management Inc. now owns 138,321 shares of the company’s stock worth $4,203,000 after buying an additional 13,498 shares during the last quarter. Finally, Legal & General Group Plc boosted its stake in shares of HealthEquity by 25.3% in the second quarter. Legal & General Group Plc now owns 9,702 shares of the company’s stock worth $291,000 after buying an additional 1,960 shares during the last quarter. 91.41% of the stock is owned by institutional investors and hedge funds.
A number of research firms have recently commented on HQY. Raymond James Financial Inc. raised their target price on HealthEquity from $32.00 to $40.00 and gave the company an “outperform” rating in a research report on Monday, September 12th. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a research report on Friday, September 9th. SunTrust Banks Inc. restated a “buy” rating on shares of HealthEquity in a research report on Thursday, September 8th. Barrington Research lifted their price objective on HealthEquity from $34.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, September 8th. Finally, Robert W. Baird lifted their price objective on HealthEquity from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Wednesday, September 7th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $36.00.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.